Proteomics

Dataset Information

0

KK-LC-1 as a feasible therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer


ABSTRACT: Failure to achieve complete elimination of triple negative breast cancer (TNBC) stem cells after adjuvant therapy is associated with poor outcomes. Aldehyde dehydrogenase 1 (ALDH1) is a marker of breast cancer stem cells (BCSCs), and its enzymatic activity regulates tumor stemness. Identifying upstream targets to control ALDH+ cells may facilitate TNBC tumor suppression. Here, we show that KK-LC-1 determines the stemness of TNBC ALDH+ cells via binding with FAT1 and subsequently promoting its ubiquitination and degradation. This compromised the Hippo pathway and led to nuclear translocation of YAP1 and ALDH1A1 transcription. These findings identified the KK-LC-1-FAT1-Hippo-ALDH1A1 pathway in TNBC ALDH+ cells as a therapeutic target. To reverse the malignancy due to KK-LC-1 expression, we employed a novel computational approach and discovered Z839878730 (Z8) as an small-molecule inhibitor which may disrupt KK-LC-1 and FAT1 binding. We demonstrate that Z8 suppressed TNBC tumor growth via a mechanism that reactivated the Hippo pathway and decreased TNBC ALDH+ cell stemness and viability.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Haonan Li  

LAB HEAD: Caigang Liu

PROVIDER: PXD040200 | Pride | 2023-04-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
BPI_19596_human_B.msf Msf
BPI_19596_human_B.raw Raw
BPI_19596_human_C.msf Msf
BPI_19596_human_C.raw Raw
Items per page:
1 - 4 of 4
altmetric image

Publications

KK-LC-1 as a therapeutic target to eliminate ALDH<sup>+</sup> stem cells in triple negative breast cancer.

Bu Jiawen J   Zhang Yixiao Y   Wu Sijin S   Li Haonan H   Sun Lisha L   Liu Yang Y   Zhu Xudong X   Qiao Xinbo X   Ma Qingtian Q   Liu Chao C   Niu Nan N   Xue Jinqi J   Chen Guanglei G   Yang Yongliang Y   Liu Caigang C  

Nature communications 20230505 1


Failure to achieve complete elimination of triple negative breast cancer (TNBC) stem cells after adjuvant therapy is associated with poor outcomes. Aldehyde dehydrogenase 1 (ALDH1) is a marker of breast cancer stem cells (BCSCs), and its enzymatic activity regulates tumor stemness. Identifying upstream targets to control ALDH<sup>+</sup> cells may facilitate TNBC tumor suppression. Here, we show that KK-LC-1 determines the stemness of TNBC ALDH<sup>+</sup> cells via binding with FAT1 and subsequ  ...[more]

Similar Datasets

2022-11-30 | GSE212889 | GEO
2017-02-05 | GSE77568 | GEO
2023-07-19 | GSE226018 | GEO
2024-07-03 | PXD053261 | Pride
2008-10-29 | GSE8045 | GEO
2008-11-13 | E-GEOD-8045 | biostudies-arrayexpress
2021-03-01 | GSE127897 | GEO
2022-02-16 | PXD023455 | Pride
2019-12-18 | PXD015495 | Pride
2018-05-22 | GSE110350 | GEO